0000914190-19-000261.txt : 20190809 0000914190-19-000261.hdr.sgml : 20190809 20190809161205 ACCESSION NUMBER: 0000914190-19-000261 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190807 FILED AS OF DATE: 20190809 DATE AS OF CHANGE: 20190809 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BAUMGARTNER ROBERT V CENTRAL INDEX KEY: 0001258704 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17272 FILM NUMBER: 191013088 MAIL ADDRESS: STREET 1: 5775 WAYZATA BOULEVARD, SUITE 400 CITY: MINNEAPOLIS STATE: MN ZIP: 55416 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-TECHNE Corp CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 411427402 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 FORMER COMPANY: FORMER CONFORMED NAME: TECHNE CORP /MN/ DATE OF NAME CHANGE: 19920703 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2019-08-07 0000842023 BIO-TECHNE Corp TECH 0001258704 BAUMGARTNER ROBERT V 5775 WAYZATA BOULEVARD, SUITE 400 MINNEAPOLIS MN 55416 1 0 0 0 Common Stock 2019-08-07 4 P 0 500 191.06 A 8726 D Stock Options (Right to Buy) 70.35 2011-10-27 2021-10-26 Common Stock 5000 5000 D Stock Options (Right to Buy) 66.90 2012-10-25 2022-10-24 Common Stock 5000 5000 D Stock Options (Right to Buy) 87.39 2013-10-31 2023-10-30 Common Stock 4000 4000 D Stock Options (Right to Buy) 91.78 2014-10-30 2024-10-30 Common Stock 4000 4000 D Stock Options (Right to Buy) 87.34 2016-10-29 2025-10-28 Common Stock 4260 4260 D Stock Options (Right to Buy) 101.19 2017-10-26 2026-10-26 Common Stock 3985 3985 D Stock Options (Right to Buy) 125.05 2018-10-25 2027-10-26 Common Stock 3125 3125 D Stock Options (Right to Buy) 179.84 2028-10-25 Common Stock 1898 1898 D This option vests on the earlier of the one year anniversary of the grant date (10/25/2019) or the date of Bio-Techne 2019 Annual Meeting of Shareholders. /s/ Brenda S. Furlow as Attorney-in-Fact for Robert V. Baumgartner pursuant to Power of Attorney previously filed. 2019-08-09